BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31474326)

  • 1. Prevalence and Clinical Impact of Iron Deficiency in Patients With Severe Aortic Stenosis Referred for Transcatheter Aortic Valve Implantation.
    Rheude T; Pellegrini C; Lessmann L; Wiebe J; Mayr NP; Michel J; Trenkwalder T; Kasel AM; Schunkert H; Kastrati A; Joner M; Husser O; Hengstenberg C
    Am J Cardiol; 2019 Nov; 124(9):1442-1448. PubMed ID: 31474326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of anemia and iron-deficiency anemia in a contemporary cohort of patients undergoing transcatheter aortic valve implantation.
    Rheude T; Pellegrini C; Michel J; Trenkwalder T; Mayr NP; Kessler T; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C; Husser O
    Int J Cardiol; 2017 Oct; 244():93-99. PubMed ID: 28645804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of Underweight (Body Mass Index <20 kg/m
    Voigtländer L; Twerenbold R; Schäfer U; Conradi L; Balaban Ü; Bekeredjian R; Ensminger S; Walther T; Beckmann A; Frerker C; Bauer T; Hamm C; Möllmann H; Bleiziffer S;
    Am J Cardiol; 2020 Aug; 129():79-86. PubMed ID: 32540167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between valvuloarterial impedance after transcatheter aortic valve implantation and 2-year mortality in elderly patients with severe symptomatic aortic stenosis: the OCEAN-TAVI registry.
    Nagura F; Kataoka A; Hara M; Kozuma K; Watanabe Y; Nakashima M; Hioki H; Kawashima H; Nara Y; Shirai S; Tada N; Araki M; Naganuma T; Yamanaka F; Ueno H; Tabata M; Mizutani K; Higashimori A; Takagi K; Yamamoto M; Hayashida K;
    Heart Vessels; 2019 Jun; 34(6):1031-1039. PubMed ID: 30599060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison in Men Versus Women of Co-morbidities, Complications, and Outcomes After Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis.
    Gaglia MA; Lipinski MJ; Torguson R; Gai J; Ben-Dor I; Bernardo NL; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2016 Dec; 118(11):1692-1697. PubMed ID: 27666174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thirty-Day Readmissions After Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis in New York State.
    Hannan EL; Samadashvili Z; Jordan D; Sundt TM; Stamato NJ; Lahey SJ; Gold JP; Wechsler A; Ashraf MH; Ruiz C; Wilson S; Smith CR
    Circ Cardiovasc Interv; 2015 Aug; 8(8):e002744. PubMed ID: 26227347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous ferric derisomaltose in iron-deficient patients undergoing transcatheter aortic valve implantation due to severe aortic stenosis: study protocol of the randomised controlled IIISAS trial.
    Bardan S; Kvaslerud AB; Andresen K; Kløve SF; Edvardsen T; Gullestad L; Broch K
    BMJ Open; 2022 Sep; 12(9):e059546. PubMed ID: 36691165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Transfemoral Transcatheter Aortic Valve Implantation in Patients With Previous Coronary Bypass.
    Leshem-Rubinow E; Abramowitz Y; Steinvil A; Ben-Assa E; Chorin E; Shacham Y; Yankelson L; Konigstein M; Keren G; Banai S; Finkelstein A
    Am J Cardiol; 2015 Aug; 116(3):431-5. PubMed ID: 26054290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous iron supplement for iron deficiency in patients with severe aortic stenosis scheduled for transcatheter aortic valve implantation: results of the IIISAS randomised trial.
    Kvaslerud AB; Bardan S; Andresen K; Kløve SF; Fagerland MW; Edvardsen T; Gullestad L; Broch K
    Eur J Heart Fail; 2022 Jul; 24(7):1269-1279. PubMed ID: 35579454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the development of transcatheter aortic valve implantation on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome.
    Bouleti C; Chauvet M; Franchineau G; Himbert D; Iung B; Alos B; Brochet E; Urena M; Ghodbane W; Ou P; Provenchere S; Nataf P; Vahanian A
    Eur J Cardiothorac Surg; 2017 Jan; 51(1):80-88. PubMed ID: 27582074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, Prognostic Impact, and Predictive Factors of Readmission for Heart Failure After Transcatheter Aortic Valve Replacement.
    Durand E; Doutriaux M; Bettinger N; Tron C; Fauvel C; Bauer F; Dacher JN; Bouhzam N; Litzler PY; Cribier A; Eltchaninoff H
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2426-2436. PubMed ID: 29217006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.
    Kedev S; Zafirovska B; Srbinovska-Kostovska E; Antov S; Nikolic A; Dzemali O; Bunc M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):5-14. PubMed ID: 31605589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of, risk factors for and impact of readmission for heart failure after successful transcatheter aortic valve implantation.
    Guedeney P; Huchet F; Manigold T; Rouanet S; Balagny P; Leprince P; Lebreton G; Letocart V; Barthelemy O; Vicaut E; Montalescot G; Guerin P; Collet JP;
    Arch Cardiovasc Dis; 2019 Dec; 112(12):765-772. PubMed ID: 31759916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron Deficiency Treatment in Patients with Heart Failure.
    Jankowska EA; Drozd M; Ponikowski P
    Handb Exp Pharmacol; 2017; 243():561-576. PubMed ID: 28405775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated clinical indications for transcatheter aortic valve implantation in patients with severe aortic stenosis: expert opinion of the Italian Society of Cardiology and GISE.
    Indolfi C; Bartorelli AL; Berti S; Golino P; Esposito G; Musumeci G; Petronio S; Tamburino C; Tarantini G; Ussia G; Vassanelli C; Spaccarotella C; Violini R; Mercuro G; Romeo F
    J Cardiovasc Med (Hagerstown); 2018 May; 19(5):197-210. PubMed ID: 29578921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Baseline Characteristics and Outcomes in Men Versus Women With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.
    Sannino A; Szerlip M; Harrington K; Schiattarella GG; Grayburn PA
    Am J Cardiol; 2018 Apr; 121(7):844-849. PubMed ID: 29397106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.
    Huczek Z; Zbroński K; Grodecki K; Scisło P; Rymuza B; Kochman J; Dąbrowski M; Witkowski A; Wojakowski W; Parma R; Ochała A; Grygier M; Olasińska-Wiśniewska A; Araszkiewicz A; Jagielak D; Ciećwierz D; Puchta D; Paczwa K; Filipiak KJ; Wilimski R; Zembala M; Opolski G
    Catheter Cardiovasc Interv; 2018 Jan; 91(1):115-123. PubMed ID: 28843025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Patients with Severe Aortic Stenosis and Left Ventricular Obstruction Undergoing Transcatheter Aortic Valve Implantation.
    Kaewkes D; Ochiai T; Flint N; Patel V; Mahani S; Raschpichler M; Yoon SH; Skaf S; Singh S; Chakravarty T; Nakamura M; Cheng W; Makkar R
    Am J Cardiol; 2020 Oct; 133():105-115. PubMed ID: 32811649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year follow-up after transcatheter aortic valve implantation for symptomatic aortic stenosis.
    Zahn R; Werner N; Gerckens U; Linke A; Sievert H; Kahlert P; Hambrecht R; Sack S; Abdel-Wahab M; Hoffmann E; Zeymer U; Schneider S;
    Heart; 2017 Dec; 103(24):1970-1976. PubMed ID: 28684438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sutureless versus Transfemoral Transcatheter Aortic Valve Implant: A Propensity Score Matching Study.
    Santarpino G; Vogt F; Pfeiffer S; Dell'Aquila AM; Jessl J; Cuomo F; von Wardenburg C; Fischlein T; Pauschinger M; Schwab J
    J Heart Valve Dis; 2017 May; 26(3):255-261. PubMed ID: 29092108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.